Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

25 June 2020: Clinical Research

Serum Amyloid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus

Cai-Mei Wang EFG , Jin-Huan Deng EFG , Guo-Fei Mao B , Yong-Ling He B , Xiang Shi AC*

DOI: 10.12659/MSM.923290

Med Sci Monit 2020; 26:e923290

Table 1 Demographic characteristics and laboratory parameters of patients with systemic lupus erythematosus (SLE) and healthy individuals.

Patients with SLEHealthy ControlsP-value
n=135n=149
Gender (Male/Female)14/12122/1270.266
Age (years)38.0 (29.0–47.0)34.0 (26.0–44.0)0.085
WBC (10/L)5.90 (3.98–9.24)6.68 (5.56–7.74)0.059
RBC (10/L)4.10±0.674.54±0.37
Platelet count (10/L)224.56±91.09250.35±37.890.003
Hemoglobin (g/L)116.0 (105.0–125.0)133.0 (128.0–140.0)
RDW (%)13.80 (12.90–15.90)12.20 (11.85–12.60)
Hs-CRP (mg/L)2.35 (0.44–7.71)0.67 (0.58–0.99)
ESR (mm/h)18.0 (11.0–35.0)
SAA (mg/L)4.90 (1.90–12.00)
SLEDAI-2k scores7.0 (5.0–15.0)
WBC – white blood cell count; RBC – red blood cell; RDW – red blood cell distribution width; Hs-CRP – hypersensitive C-reactive protein; ESR – erythrocyte sedimentation rate; SAA – serum amyloid A; SLEDAI-2K – SLE Disease Activity Index 2000.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750